Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses.
about
CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanismsInvolvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.Genes, tolerance and systemic autoimmunityInteractions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interactionThe immunomodulatory proteins B7-DC, B7-H2, and B7-H3 are differentially expressed across gestation in the human placentaEngagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activationMelanoma: oncogenic drivers and the immune systemThe anticancer immune response of anti-PD-1/PD-L1 and the genetic determinants of response to anti-PD-1/PD-L1 antibodies in cancer patientsNivolumab in the treatment of malignant melanoma: review of the literatureHigh-Resolution PET Imaging with Therapeutic Antibody-based PD-1/PD-L1 Checkpoint TracersAspirin-treated human DCs up-regulate ILT-3 and induce hyporesponsiveness and regulatory activity in responder T cellsMarginal-zone B cellsAssociation of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitopeThe role of the PD-1 pathway in autoimmunity and peripheral toleranceBTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1Role of interferon-γ and cytotoxic T lymphocytes in intraocular tumor rejection.Chronically inflamed livers up-regulate expression of inhibitory B7 family members.PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cellsSoluble Programmed Death 1 (PD-1) Is Decreased in Patients With Immune Thrombocytopenia (ITP): Potential Involvement of PD-1 Pathway in ITP Immunopathogenesis.Octamer binding protein 2 (Oct2) regulates PD-L2 gene expression in B-1 cells through lineage-specific activity of a unique, intronic promoter.Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivoThe role of co-inhibitory signals in spontaneous tolerance of weakly mismatched transplantsPD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cellsDepletion of the programmed death-1 receptor completely reverses established clonal anergy in CD4(+) T lymphocytes via an interleukin-2-dependent mechanism.PD-1 regulates T cell proliferation in a tissue and subset-specific manner during normal mouse pregnancyPD-1, gender, and autoimmunity.Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes.PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.Deficiency in B7-H1 (PD-L1)/PD-1 coinhibition triggers pancreatic beta-cell destruction by insulin-specific, murine CD8 T-cells.Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis.Association of PDCD1 genetic variation with risk and clinical manifestations of systemic lupus erythematosus in a multiethnic cohort.The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function.Programmed Death-1 antibody blocks therapeutic effects of T-regulatory cells in cockroach antigen-induced allergic asthma.Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia.Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escapeAcute depletion of activated memory B cells involves the PD-1 pathway in rapidly progressing SIV-infected macaques.PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta.Simultaneous blockade of multiple immune system inhibitory checkpoints enhances antitumor activity mediated by interleukin-15 in a murine metastatic colon carcinoma modelRole of PD-1 co-inhibitory pathway in HIV infection and potential therapeutic options
P2860
Q24534904-7F79E508-0978-465D-91DA-AF2C8763EBC7Q24535835-06A253B8-1E2D-4F78-90F4-847ED1976FB5Q24615454-089F6814-F482-45CE-90DC-AA38160CF9A7Q24655516-6A0D5E18-E3EB-45BB-916D-BB596CBE9879Q24673269-5677363B-9681-4A52-A22F-8051CE3F7307Q24675388-E4DAC9BC-1620-4B16-93CF-CBD51EB039A8Q24675931-FCDCED11-D25F-4F3C-8EEF-214B73F69B78Q26775598-D3099781-B7B8-4A58-BBE9-57D84E0597AFQ26797478-D6765D7D-C7C1-43E9-9E89-F4A78C538BE4Q26798330-DE0FCC39-8DA7-438D-AF41-71CC6A8C42C7Q27300777-FFA34F06-20E7-43AC-A768-AFD0FB3E334BQ28199779-94EB8CBB-305B-4788-A2B2-6CA5D785C20FQ28201000-76678929-A347-450C-88DE-717158C91D74Q28266117-A3141185-8357-4724-B1AB-8DEB898F831CQ28304161-6BEEA9BF-858E-4645-8D52-D889179B256DQ28589743-20617E60-5620-4080-AB67-69A2D62641A2Q30357718-1FDC8F80-86BF-40FD-BC9A-54890E391CB0Q30434304-817EB8D1-F3F9-4E55-B6E8-3BBB564435F3Q30488777-1C58259A-B14A-40E8-9128-9D55172CF03FQ33419344-F22EF184-9D41-4C13-9EF7-78A0B610201AQ33601667-7FF2AFE2-EE10-48EF-BB7F-0807873F3641Q33615157-CC2ED743-0316-4976-A179-37CF9822AD05Q33648838-A2954E12-3775-4CA6-B545-0131C46A5CCDQ33866996-A0567D0F-A801-41C5-85C9-F004458B90E7Q33877649-47617699-018E-4A03-BAA9-A5D682D13847Q33893319-F733674E-CA1D-4FCA-8EB9-41C2B129267AQ33910421-1108DF85-35A3-449A-AA09-7F62CEBB7428Q33920287-F68A0874-8E02-4D41-A92C-0B5B017795B3Q33950150-B3A35531-2E7E-4DCA-B1FB-FC36C594BD51Q34024395-3F0C998E-F071-4157-A77C-BAF5D924B184Q34067889-C7F2CBA4-F413-4DF8-BCBA-1B9285058782Q34079062-D5D5439F-8583-49C4-B375-3DDF104EE72EQ34165325-698C0237-4B6B-477C-ADCC-A9134D0ED586Q34184819-E71E13EE-6810-42B5-8048-3C66E892224FQ34193534-8DBA1B94-097A-4DAC-B87F-8C967D61DAE5Q34241893-04D71E3D-FDCA-4C68-A81D-6EC73E786BA8Q34245386-9FD29BA5-85D0-44B5-AD24-D64AB871A6C7Q34347206-445E8316-470A-462F-A5D4-75CC9E8D01B9Q34420239-65626FC2-72BA-4F76-8FBE-D5DF5E029168Q34466498-47D1BE2A-B202-4B84-A472-DDE7D245E56B
P2860
Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses.
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Immunological studies on PD-1 ...... egulator for B cell responses.
@ast
Immunological studies on PD-1 ...... egulator for B cell responses.
@en
Immunological studies on PD-1 ...... egulator for B cell responses.
@nl
type
label
Immunological studies on PD-1 ...... egulator for B cell responses.
@ast
Immunological studies on PD-1 ...... egulator for B cell responses.
@en
Immunological studies on PD-1 ...... egulator for B cell responses.
@nl
prefLabel
Immunological studies on PD-1 ...... egulator for B cell responses.
@ast
Immunological studies on PD-1 ...... egulator for B cell responses.
@en
Immunological studies on PD-1 ...... egulator for B cell responses.
@nl
P2093
P356
P1476
Immunological studies on PD-1 ...... egulator for B cell responses.
@en
P2093
P304
P356
10.1093/INTIMM/10.10.1563
P577
1998-10-01T00:00:00Z